ネクスジェル
NEXGEL, Inc.
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.11 | $3M | -$513,000 |
| 2025 Q4 | -0.12 | $3M | $309,000 |
| 2025 Q3 | -0.08 | $3M | -$793,000 |
| 2025 Q2 | -0.09 | $3M | -$427,000 |
| 2025 Q1 | -0.09 | $3M | -$400,000 |
| 2024 Q4 | -0.12 | $3M | -$928,000 |
| 2024 Q3 |
| -0.11 |
| $3M |
| -$1M |
| 2024 Q2 | -0.14 | $1M | -$909,000 |